Katharina Semke
Follow Katharina Semke
Articles by Katharina Semke
Compeon raises €2.5m series-A from Tengelmann et al.
Company was founded in 2012
Partech invests in Chronext's $5.3m round
Competitor Chrono24 raised €21m in July
Speedinvest backs Hitbox's $4m series-A
Company attracted fresh capital from international investors
Figo raises seven-digit sum from HTGF et al.
Company was founded in 2012
CureVac raises €100m from Baillie Gifford et al.
Funding round is among the largest capital increases in German biotech
HTGF announces collaboration with Chinese investment bank
Joint venture follows inter-governmental consultations
Constellation buys Faircheck
GP will apply buy-and-build strategy
HTGF backs Soley
Company is a spin-off from TU Munich
Orange and Publicis launch new VC fund
First close planned for 2016
Deutsche Telekom rebrands T-Venture as DTSI
Deutsche Telekom delayed restructuring by a year
Germany: Generational shift the answer to cultural conundrum
As dealflow in Germany remains subdued, could a new generation bring about change?
Catapult exits System Integration in management buy-back
Catapult exits business after six years
Wellington-backed Neuway extends series-A to €5.85m
Company is first spinout from Life Science Inkubator
Barclays spins out natural resources unit in MBO
New GP GNRI operates out of London and Doha
Life Sciences Partners' Curetis sets IPO price range
Company hopes to raise up to €50m
EQT's Sportradar scores $44m funding round
Existing investor EQT stays on board, Michael Jordan joins
Creathor backs Knip's $15.7m series-B
Route 66 and QED also take part in round
Acton Capital closes second fund on €170m
Fund made three investments before official close
HTGF backs Enoware
Company is spin-off from Systec & Services
CommerzVentures et al. invest in GetSafe
Company is backed by Rocket Internet
Sequana Medical raises CHF 9m series-C extension
New investors Salus Partners and Quest for Growth provide CHF 3.7m
Leithner to join EQT from Deutsche Bank
Leithner criticised for Deutsche involvement in Libor scandal
Equistone's Concept Life Sciences bolts on Agenda1
Acquisition part of buy-and-build strategy
Emeram buys Matrix42
Company is Emeram's fourth acquisition